Search Results

You are looking at 101 - 110 of 378 items for :

  • "early detection" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access


and adversely affect Medicare beneficiaries, Medicare, and the US healthcare system as a whole. With access to more early detection, individuals would be able to detect cancer earlier when it is more easily treated, better understand their personal

Full access

EPR22-109: Cancer Incidence in Immunocompromised Patients

Sabrina Ilham, Connor Willis, Kibum Kim, Karen Chung, Brenda Wood, Malinda Tan, Danielle Nguyen, Diana Brixner, and David Stenehjem

significantly increased risk of CA was observed among PID/SID and SOT/HSCT pts compared to TNF-i pts. Age ≥50 yrs, male gender, and CCI score of ≥6 were additional factors impacting CA risk and can inform early detection strategies. Table 1: Risk Factors

Full access


continues to cause distress and confusion for many men, especially when they read about the controversies associated with the use of prostate-specific antigen (PSA) for the early detection of prostate cancer, noted Dr. Mohler. “The NCCN Guidelines Panel

Full access

Breast Awareness: A Shift in the Paradigm of Breast Self-Examination

Therese B. Bevers

societies, breast cancer advocacy groups, and the media as an effective screening tool. BSE has been an integral part of breast cancer screening recommendations for many years. Although BSE was first presented in the 1930s as a tool in the early detection

Full access

Prostate Cancer Screening and Determining the Appropriate Prostate-Specific Antigen Cutoff Values

William J. Catalona and Stacy Loeb

screening. Advantages Associated with Using a Lower PSA Threshold The FDA approved the PSA test for monitoring patients with established CaP in 1986, and in 1994 approved PSA as an aid for early detection of CaP, using 4 ng/mL as the upper limit of

Full access

Current Surveillance After Treatment is Not Sufficient for Patients With Rectal Cancer With Negative Baseline CEA

Dingcheng Shen, Xiaolin Wang, Heng Wang, Gaopo Xu, Yumo Xie, Zhuokai Zhuang, Ziying Huang, Juan Li, Jinxin Lin, Puning Wang, Meijin Huang, Yanxin Luo, and Huichuan Yu

Moreover, one study showed that patients under strict surveillance after treatment had 5-year recurrence-free survival rates that increased from 69% to 94%. 6 These studies indicate that early detection of recurrent disease is of significance in improving

Full access

Point: Impact of Prostate-Specific Antigen Velocity on Management Decisions and Recommendations

Stacy Loeb and H. Ballentine Carter

and the diagnosis of low-risk prostate cancer. Correspondingly, PSAV risk count was recently added as a talking point in the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection (to view the most

Full access

Coordination of Genetic Care: More Important and Complicated Than it Seems

Suzanne M. Mahon

pathogenic mutation. 13 Missed Opportunities for Cancer Prevention and Early Detection It is also not clear what the medical oncologist communicated to the daughter about risks to other relatives or whether a pedigree was constructed. There was no history of

Full access

Lung Cancer Screening: The Last 10 Years

Douglas E. Wood

For decades, experts advocated early detection of common cancers to improve chances for long-term survival and cure. Breast, colon, and prostate cancers all have established screening programs that are covered by insurers, embraced by physicians

Full access

Differences in Patient Screening Mammography Rates Associated With Internist Gender and Level of Training and Change Following the 2009 U.S. Preventive Services Task Force Guidelines

Dawn J. Brooks

Breast cancer is currently the second greatest cause of cancer-related death in women living in the United States, with approximately 40,000 women dying annually from complications of breast cancer. 1 As a result of both earlier detection through